NRx Pharmaceuticals (NASDAQ:NRXP) Earns “Buy” Rating from D. Boral Capital
NRx Pharmaceuticals (NASDAQ:NRXP – Get Free Report)‘s stock had its “buy” rating reaffirmed by D. Boral Capital in a research report issued to clients and investors on Monday,Benzinga reports. They presently have a $31.00 price objective on the stock. Other equities analysts also recently issued research reports about the stock. Ascendiant Capital Markets boosted their […]
NRx Pharmaceuticals (NASDAQ:NRXP – Get Free Report)‘s stock had its “buy” rating reaffirmed by D. Boral Capital in a research report issued to clients and investors on Monday,Benzinga reports. They presently have a $31.00 price objective on the stock. Other equities analysts also recently issued research reports about the stock. Ascendiant Capital Markets boosted their […]
